首页> 美国卫生研究院文献>Diabetes Technology Therapeutics >Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients
【2h】

Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients

机译:利用基于云的糖尿病管理程序来启动和滴定胰岛素可以在医疗服务提供者和患者之间进行协作决策

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Overseeing proper insulin initiation and titration remains a challenging task in diabetes care. Recent advances in mobile technology have enabled new models of collaborative care between patients and healthcare providers (HCPs). We hypothesized that the adoption of such technology could help individuals starting basal insulin achieve better glycemic control compared with standard clinical practice.>Materials and Methods: This was a 12 ± 2-week randomized controlled study with 40 individuals with type 2 diabetes who were starting basal insulin due to poor glycemic control. The control group (n = 20) received standard face-to-face care and phone follow-up as needed in a tertiary center, whereas the intervention group (n = 20) received care through the cloud-based diabetes management program where regular communications about glycemic control and insulin doses were conducted via patient self-tracking tools, shared decision-making interfaces, secure text messages, and virtual visits (audio, video, and shared screen control) instead of office visits.>Results: By intention-to-treat analysis, the intervention group achieved a greater hemoglobin A1c decline compared with the control group (3.2 ± 1.5% vs. 2.0% ± 2.0%; P = 0.048). The Diabetes Treatment Satisfaction Questionnaire showed a significant improvement in the intervention group compared with the control group (an increase of 10.1 ± 11.7 vs. 2.1 ± 6.5 points; P = 0.01). HCPs spent less time with patients in the intervention group compared with those in the control group (65.9 min per subject vs. 81.6 min per subject). However, the intervention group required additional training time to use the mobile device.>Conclusions: Mobile health technology could be an effective tool in sharing data, enhancing communication, and improving glycemic control while enabling collaborative decision making in diabetes care.
机译:>背景:在糖尿病护理中,监督适当的胰岛素起始和滴定仍然是一项艰巨的任务。移动技术的最新进展为患者和医疗保健提供者(HCP)之间的协作医疗提供了新的模式。我们假设采用这种技术可以比标准的临床实践帮助开始基础胰岛素治疗的患者实现更好的血糖控制。>材料和方法:这是一项为期12±2周的随机对照研究,其中40例患者由于血糖控制不良而开始使用基础胰岛素的2型糖尿病。对照组(n = 20)在三级中心根据需要接受了标准的面对面护理和电话随访,而干预组(n = 20)则通过基于云的糖尿病管理计划进行了定期沟通,从而获得了护理。通过患者自我跟踪工具,共享的决策界面,安全的短信和虚拟访问(音频,视频和共享屏幕控制)而不是办公室访问来进行有关血糖控制和胰岛素剂量的研究。>结果:通过意向性治疗分析,干预组的血红蛋白A1c下降较对照组更大(3.2%±1.5%vs. 2.0%±2.0%; P = 0.048)。糖尿病治疗满意度问卷显示,干预组与对照组相比有显着改善(增加了10.1±11.7点,而相对于2.1±±6.5点; P = 0.01)。与对照组相比,干预组中的HCP花费的时间更少(每名受试者65.9分钟,而每名受试者81.6分钟)。但是,干预小组需要额外的培训时间才能使用移动设备。>结论:移动健康技术可以成为共享数据,增强交流和改善血糖控制的有效工具,同时可以在糖尿病患者中进行协作决策关心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号